Hel Ved Capital Management’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.31M Sell
24,844
-2,430
-9% -$543K 0.63% 24
2025
Q4
$4.67M Buy
+27,274
New +$4.24M 1.25% 26
2025
Q3
Sell
-28,450
Closed -$2.77M 94
2025
Q2
$2.77M Sell
28,450
-105,250
-79% -$8.35M 0.73% 39
2025
Q1
$9.72M Buy
+133,700
New +$10.5M 3.51% 7
2023
Q4
Sell
-3,320
Closed -$208K 60
2023
Q3
$208K Buy
+3,320
New +$218K 0.07% 43
2022
Q4
Sell
-304,730
Closed -$11.2M 16
2022
Q3
$11.2M Sell
304,730
-626,990
-67% -$27.9M 8.58% 4
2022
Q2
$39.7M Buy
+931,720
New +$44.4M 24.34% 1
2021
Q1
$19.6M Buy
+364,000
New +$19.8M 16.76% 3

Other funds holding LRCX

Hel Ved Capital Management's LRCX Position: Q1 2026 in Review

Hel Ved Capital Management reduced its Lam Research (LRCX) stake by 8.9% in Q1 2026, selling an estimated $543K and leaving 24,844 shares worth $5.31M. The position accounts for 0.63% of the portfolio, ranked #24.

Hel Ved Capital Management first reported a position in LRCX in Q1 2021 and has held it in 8 quarters since. The position peaked at $39.7M in Q2 2022. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • Hel Ved Capital Management held 24,844 shares of Lam Research worth $5.31M as of Q1 2026.
  • Hel Ved Capital Management sold 2,430 Lam Research shares in Q1 2026, an estimated $543K.
  • Lam Research made up 0.63% of Hel Ved Capital Management's portfolio in Q1 2026, its #24 holding.
  • Hel Ved Capital Management first reported a position in Lam Research in Q1 2021 and has held it in 8 quarters since.
  • Hel Ved Capital Management's Lam Research position peaked at $39.7M in Q2 2022.
  • 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Hel Ved Capital Management's 13F filing for Q1 2026, filed 15 May 2026.